115 related articles for article (PubMed ID: 30529193)
1. Overexpression of TBL1XR1 confers tumorigenic capability and promotes recurrence of osteosarcoma.
Xi X; Wu Q; Bao Y; Lin M; Zhong X; Dai X; Lin H
Eur J Pharmacol; 2019 Feb; 844():259-267. PubMed ID: 30529193
[TBL] [Abstract][Full Text] [Related]
2. TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma.
Liu L; Lin C; Liang W; Wu S; Liu A; Wu J; Zhang X; Ren P; Li M; Song L
Gut; 2015 Jan; 64(1):26-36. PubMed ID: 24667177
[TBL] [Abstract][Full Text] [Related]
3. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
[TBL] [Abstract][Full Text] [Related]
4. Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-κB pathway.
Chen SP; Yang Q; Wang CJ; Zhang LJ; Fang Y; Lei FY; Wu S; Song LB; Guo X; Guo L
Mol Cancer; 2014 Aug; 13():195. PubMed ID: 25145705
[TBL] [Abstract][Full Text] [Related]
5. Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.
Li X; Liang W; Liu J; Lin C; Wu S; Song L; Yuan Z
Breast Cancer Res; 2014 Oct; 16(5):465. PubMed ID: 25341494
[TBL] [Abstract][Full Text] [Related]
6. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
7. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.
Zhang S; Wang Y; Chen S; Li J
Biomed Pharmacother; 2018 Oct; 106():1396-1403. PubMed ID: 30119212
[TBL] [Abstract][Full Text] [Related]
8. Correlations between TBL1XR1 and recurrence of colorectal cancer.
Liu H; Xu Y; Zhang Q; Li K; Wang D; Li S; Ning S; Yang H; Shi W; Liu Z; Chen Y
Sci Rep; 2017 Mar; 7():44275. PubMed ID: 28295012
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH
Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885
[TBL] [Abstract][Full Text] [Related]
10. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
Ma M; Yu N
Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma.
Wang J; Cao L; Wu J; Wang Q
Int J Oncol; 2018 Jan; 52(1):77-88. PubMed ID: 29115574
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
Chen F; Mo J; Zhang L
Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells.
Zuo D; Shogren KL; Zang J; Jewison DE; Waletzki BE; Miller AL; Okuno SH; Cai Z; Yaszemski MJ; Maran A
J Exp Clin Cancer Res; 2018 Oct; 37(1):244. PubMed ID: 30286779
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
Cong M; Li J; Jing R; Li Z
Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
[TBL] [Abstract][Full Text] [Related]
15. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma.
Ma C; Zhan C; Yuan H; Cui Y; Zhang Z
Oncol Rep; 2016 Jun; 35(6):3257-64. PubMed ID: 27035098
[TBL] [Abstract][Full Text] [Related]
18. Defective autophagy leads to the suppression of stem-like features of CD271
Zhang D; Zhao Q; Sun H; Yin L; Wu J; Xu J; He T; Yang C; Liang C
J Biomed Sci; 2016 Nov; 23(1):82. PubMed ID: 27863492
[TBL] [Abstract][Full Text] [Related]
19. Twist2 functions as a tumor suppressor in murine osteosarcoma cells.
Ishikawa T; Shimizu T; Ueki A; Yamaguchi SI; Onishi N; Sugihara E; Kuninaka S; Miyamoto T; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Mabuchi Y; Matsuzaki Y; Yamaguchi R; Miyano S; Saya H
Cancer Sci; 2013 Jul; 104(7):880-8. PubMed ID: 23557174
[TBL] [Abstract][Full Text] [Related]
20. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
